EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prediction of major arrhythmic outcomes in ischaemic cardiomyopathy: value of hibernating myocardium in positron emission tomography/computed tomography

Boldizsar Kovacs iD, Valon Gllareva, Frank Ruschitzka, Firat Duru iD, Philipp A Kaufmann iD, Ronny R Buechel, Dominik C Benz iD, Ardan M Saguner

European Heart Journal - Cardiovascular Imaging · 2024

DOI: 10.1093/ehjci/jeae232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2024. Verfasst von Boldizsar Kovacs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Myocardial Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation Mobility Fellowship, Swiss Rhythmology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Known predictors of major arrhythmic events (MAEs) in patients with ischaemic cardiomyopathy (ICM) include previous MAE and left ventricular ejection fraction (LVEF) ≤ 35%. Myocardial scars detected by perfusion imaging in ICM have been linked to MAE, but the prognostic significance of hibernating myocardium (HM) is unclear. The objective was to predict MAEs from combined 13N-ammonia (NH3) and 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in ICM. Methods and results Consecutive patients with ICM undergoing combined NH3- and FDG-PET/CT were included. HM was quantified in relation to total left ventricular myocardium (i.e. ≥7% is large). The primary outcome was MAEs [sudden cardiac death, implantable cardioverter defibrillator (ICD) therapy, and sustained ventricular tachycardia/fibrillation]. Among 254 patients, median baseline LVEF was 35% [interquartile range (IQR) 28–45] and 10% had an ICD. PET/CT identified ischaemia in 94 (37%), scar in 229 (90%), and HM in 195 (77%) patients. Over a median follow-up of 5.4 (IQR 2.2–9.5) years, MAE occurred in 34 patients (13%). Large HM was associated with a lower incidence of MAE (hazard ratio 0.31, 95% confidence interval 0.1–0.8, P = 0.001). After multivariate adjustment for history of MAE, LVEF ≤35%, and scar ≥10%, large HM remained significantly associated with a lower incidence of MAE (P = 0.016). LVEF improved over time among patients with large HM (P = 0.006) but did not change in those without (P = 0.610) or small HM (P = 0.240).

Conclusion

HM conveys a lower risk of MAE in patients with ICM. This may be explained by an increase in LVEF when a large extent of HM is present.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Myocardial IschemiaHumansMaleFemaleMiddle AgedAgedPrognosisPredictive Value of TestsMyocardial StunningRadiopharmaceuticalsRetrospective StudiesArrhythmias, CardiacRisk AssessmentCohort StudiesCardiomyopathiesStroke Volume

Stichwörter der Autor:innen

FDG-PEThibernating myocardiummyocardial viabilitysudden cardiac deathventricular fibrillationventricular tachycardia

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
  • Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
  • Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
  • Center for Integrative Human Physiology, University Zurich, Zurich, Switzerland.
  • Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.

ORCID-Profile: Boldizsar Kovacs, Firat Duru, Philipp A Kaufmann, Dominik C Benz

Förderung

  • Swiss National Science Foundation Mobility Fellowship
  • Swiss Rhythmology Foundation

Zitieren

APA

Kovacs, B., Gllareva, V., Ruschitzka, F., Duru, F., Kaufmann, P. A., Buechel, R. R., Benz, D. C., & Saguner, A. M. (2024). Prediction of major arrhythmic outcomes in ischaemic cardiomyopathy: value of hibernating myocardium in positron emission tomography/computed tomography. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jeae232

Vancouver

Kovacs B, Gllareva V, Ruschitzka F, Duru F, Kaufmann PA, Buechel RR, et al. Prediction of major arrhythmic outcomes in ischaemic cardiomyopathy: value of hibernating myocardium in positron emission tomography/computed tomography. European Heart Journal - Cardiovascular Imaging. 2024. doi:10.1093/ehjci/jeae232

BibTeX
@article{Kovacs2024,
  author = {Kovacs, Boldizsar and Gllareva, Valon and Ruschitzka, Frank and Duru, Firat and Kaufmann, Philipp A and Buechel, Ronny R and Benz, Dominik C and Saguner, Ardan M},
  title = {Prediction of major arrhythmic outcomes in ischaemic cardiomyopathy: value of hibernating myocardium in positron emission tomography/computed tomography},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2024},
  doi = {10.1093/ehjci/jeae232}
}
Kostenlos starten →